Facebook tracking pixel
N17.9
ICD-10-CM
Acute Kidney Injury

Understanding Acute Kidney Injury (AKI), also known as Acute Renal Failure, is crucial for accurate clinical documentation and medical coding. This resource provides information on AKI diagnosis, including symptoms, causes, and treatment, to support healthcare professionals in proper coding and documentation practices. Learn about the latest guidelines for diagnosing and managing Acute Kidney Injury and Acute Renal Failure, ensuring comprehensive patient care and accurate medical records.

Also known as

Acute Renal Failure
AKI

Diagnosis Snapshot

Key Facts
  • Definition : Sudden decline in kidney function, causing waste buildup in the body.
  • Clinical Signs : Decreased urine output, swelling, fatigue, nausea, shortness of breath.
  • Common Settings : Hospitalized patients, severe infections, dehydration, certain medications.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC N17.9 Coding
N17-N19

Acute kidney failure and chronic kidney disease

Covers various stages of acute kidney injury and chronic kidney disease.

R39.8

Other urinary symptoms

Includes unspecified urinary symptoms that may accompany acute kidney injury.

I95.9

Hypotension, unspecified

Can be a cause or consequence of acute kidney injury.

T79.4XXA

Traumatic acute kidney failure

Acute kidney injury specifically caused by trauma.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is the AKI due to drugs/toxins?

Code Comparison

Related Codes Comparison

When to use each related code

Description
Sudden kidney function decline.
Gradual kidney function loss.
Kidney damage from reduced blood flow.

Documentation Best Practices

Documentation Checklist
  • AKI diagnosis: Document serum creatinine and urine output.
  • Acute Kidney Injury: Specify stage (1, 2, 3) based on KDIGO.
  • Acute Renal Failure: Document cause (prerenal, intrinsic, postrenal).
  • Document AKI duration and related comorbidities.
  • AKI coding: Use ICD-10 code N17.9 for unspecified AKI.

Coding and Audit Risks

Common Risks
  • Unspecified AKI

    Coding AKI without specifying stage (I, II, III) or cause can lead to lower reimbursement and inaccurate severity reflection.

  • AKI vs. CKD Confusion

    Misdiagnosis between acute and chronic kidney disease can impact coding accuracy, quality metrics, and treatment plans.

  • Comorbidity Documentation

    Insufficient documentation of comorbidities like hypertension or diabetes impacting AKI can affect risk adjustment and coding specificity.

Mitigation Tips

Best Practices
  • Hydration: Optimize fluid intake to maintain kidney function. ICD-10 N17
  • Medication review: Avoid nephrotoxic drugs. RxNorm, CDI, quality measures
  • Monitor renal function: Regular creatinine, GFR checks. SNOMED CT, compliance
  • Control comorbidities: Manage diabetes, hypertension. HCC coding, risk adjustment
  • Early diagnosis: Prompt treatment crucial for AKI. ICD-10, clinical validity

Clinical Decision Support

Checklist
  • Verify serum creatinine increase >=0.3 mg/dL within 48 hours (ICD-10 N17.9)
  • Check urine output <0.5 mL/kg/hour for 6 hours (AKI staging, patient safety)
  • Review medications for nephrotoxicity (drug-induced AKI, documentation)
  • Assess fluid status for hypovolemia (prerenal AKI, clinical evaluation)

Reimbursement and Quality Metrics

Impact Summary
  • Acute Kidney Injury (AKI) reimbursement impacts depend on accurate ICD-10-CM coding (N17) and staging documentation for optimal MS-DRG assignment.
  • AKI coding accuracy directly affects hospital quality reporting metrics for acute kidney problems and complications.
  • Proper AKI documentation impacts severity level and can influence hospital Value-Based Purchasing program performance.
  • Timely diagnosis and treatment of AKI, reflected in coding, impacts hospital readmission rates and associated penalties.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes. Our AI-powered assistant ensures compliance and reduces coding errors.

Frequently Asked Questions

Common Questions and Answers

Q: How can I differentiate prerenal acute kidney injury from intrinsic acute kidney injury in a clinically challenging patient?

A: Differentiating prerenal AKI from intrinsic AKI requires a multifaceted approach considering clinical history, physical exam, and laboratory data. Prerenal AKI often stems from decreased renal perfusion, as seen in hypovolemia or heart failure, and typically responds to fluid resuscitation. Examine for signs of dehydration, hypotension, and assess cardiac function. Intrinsic AKI involves structural damage within the kidney, such as acute tubular necrosis (ATN) or glomerulonephritis. Look for a history of nephrotoxic drug exposure, autoimmune diseases, or recent infections. Laboratory markers can provide further clues. A fractional excretion of sodium (FENa) less than 1% often suggests prerenal AKI, while a FENa greater than 2% is more indicative of intrinsic AKI. However, FENa interpretation can be confounded by diuretic use. Urine microscopy can identify casts suggestive of ATN or glomerulonephritis. Explore how integrating these factors can improve diagnostic accuracy in complex cases of AKI. Consider implementing standardized protocols for AKI evaluation to ensure timely and appropriate management.

Q: What are the latest evidence-based guidelines for managing acute kidney injury in patients with sepsis?

A: Managing AKI in patients with sepsis necessitates a multidisciplinary approach focusing on prompt identification and treatment of the underlying infection while optimizing renal perfusion and function. The Surviving Sepsis Campaign guidelines emphasize early fluid resuscitation, vasopressor support if needed to maintain adequate mean arterial pressure, and appropriate antibiotic therapy. Renal replacement therapy (RRT) is indicated for life-threatening complications of AKI, such as severe fluid overload, refractory hyperkalemia, or metabolic acidosis. The choice of RRT modality, whether continuous venovenous hemofiltration (CVVH) or intermittent hemodialysis (IHD), should be individualized based on patient hemodynamic stability and resource availability. Close monitoring of fluid balance, electrolyte levels, and acid-base status is crucial. Learn more about the latest evidence-based strategies for preventing and managing AKI in critically ill septic patients to improve outcomes.

Quick Tips

Practical Coding Tips
  • Code N17.9 for unspecified AKI
  • Document RIFLE criteria for AKI staging
  • Specify cause of AKI when known
  • Query physician for unclear AKI etiology
  • Consider RRT coding with AKI

Documentation Templates

Patient presents with acute kidney injury (AKI), also known as acute renal failure, evidenced by a rapid decline in glomerular filtration rate (GFR) over [number] hoursdaysweeks.  Presenting symptoms include [list symptoms e.g., oliguria, anuria, edema, fatigue, dyspnea, nausea, vomiting].  Serum creatinine is elevated at [value] mgdL, a significant increase from baseline [value] mgdL.  Blood urea nitrogen (BUN) is also elevated at [value] mgdL.  Urinalysis reveals [findings e.g., proteinuria, hematuria, casts].  The patient's medical history includes [list relevant medical history e.g., hypertension, diabetes, heart failure, nephrotoxic drug use].  Differential diagnosis includes prerenal azotemia, intrinsic renal failure, and postrenal obstruction.  Initial treatment plan includes [list treatments e.g., intravenous fluids, monitoring of electrolytes and fluid balance, discontinuation of nephrotoxic medications].  Renal ultrasound ordered to evaluate for structural abnormalities and assess kidney size.  The etiology of AKI is suspected to be [state suspected cause e.g., prerenal due to dehydration, intrinsic due to acute tubular necrosis, postrenal due to obstruction].  Prognosis and further management will depend on the underlying cause and the patient's response to initial therapy.  ICD-10 code N17.9, Acute kidney failure, unspecified, is documented.  This diagnosis will be continually reassessed and updated as the patient's condition evolves.